PubMed · 2005 · 13 citations · 0 references
Life SciencesImmunologyMolecular BiologyAutoimmunityImmunopathologyRheumatologyAutoantibodiesAutoimmune DiseasesAutoimmune Rheumatic DiseasesB Cell BiologySystemic Lupus ErythematosusToll-like ReceptorsAntinuclear Antibody PositivityB Cell - Mediated AutoimmunityB Cell DysfunctionB-cell PathogenesisDisease Activity MeasurementPeripheral Blood Lymphocyte AnalysisSystemic Lupus Erythematosus AssociationsSystemic Lupus Erythematosus Diagnostics
B cells lacking RP105 molecule, a member of the Toll-like receptor family, were increased in the peripheral blood of 2 patients with antinuclear antibody (ANA) negative systemic lupus erythematosus (SLE). The increased proportion of RP105-lacking B cells was associated with disease activity in patients with ANA-negative SLE. When there are no significant serological markers for SLE, analysis of expression of RP105 may be helpful in evaluation of activity in ANA-negative SLE. We describe a new approach, using phenotyping of B cells, to evaluate activity of ANA-negative SLE.